CGT-6321

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCGT-6321
Drug Alias NameCGT-6321CGT6321
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFibroblast growth factor receptors antagonistsVascular endothelial growth factor receptor antagonists
TargetsFibroblast growth factor receptorsVascular endothelial growth factor receptor
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesCgenetech(Suzhou China) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesCgenetech(Suzhou China) Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A